Registry for granulomatous mastitis
Part of Digestive system, Genetic & congenital, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This study is creating a registry (a database) for people with a rare inflammatory breast condition called granulomatous mastitis. It aims to learn more about the disease and how it affects people, without testing any new treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with a rare type of breast inflammation called idiopathic granulomatous mastitis (or a specific subtype).
- This diagnosis must have been made by a tissue sample (biopsy) or after surgery.
- The first diagnosis must have happened on or after January 1, 2015.
- You need to be at least 18 years old.
- Your mastitis must not be caused by other conditions like tuberculosis, sarcoidosis, a fungal or parasitic infection, or a reaction to a foreign object.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different surgical methods for treating granulomatous mastitis, a rare inflammatory breast condition. It aims to find which approach works best for patients who can safely have surgery.
This trial tests a medicine called tocilizumab for a painful breast condition called granulomatous lobular mastitis that has not improved with steroids. It may help reduce inflammation and avoid surgery.
This study compares two treatments for a rare breast inflammation called granulomatous mastitis. Half the participants will receive steroids, and the other half will receive methotrexate, to see which works better at reducing inflammation and symptoms.
This study compares two common treatments—antibiotics versus corticosteroid pills—to see which works better for granulomatous lobular mastitis (GLM), a type of breast inflammation. Participating may help find the best way to treat your condition.
This trial tests whether injecting a steroid directly into the breast can treat a condition called idiopathic granulomatous mastitis (IGM), which causes inflammation and lumps in the breast. The goal is to see if this treatment helps reduce symptoms without needing surgery.
This study collects medical data and biological samples from people diagnosed with systemic granulomatosis (a condition where tiny clumps of immune cells form in organs) to better understand the disease. It may help develop better treatments in the future.
Hear when a new Idiopathic Granulomatous Mastitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.